ProteoThera Overview
- Year Founded
-
2012
- Status
-
Out of Business
- Employees
-
7
- Latest Deal Type
-
Out of Business
ProteoThera General Information
Description
Developer of a drug targeting technology designed to improve clinical efficacy. The company's technology can generate new pharmacokinetic profiles for therapies, transforming systemically delivered drugs into locally or subcutaneous delivered proteins, peptides and small molecules, enabling medical practitioners to improve the safety profile by reducing or eliminating side effects associated with whole-body systemic exposure.
Contact Information
Website
www.proteothera.comCorporate Office
- 2227 Washington Street
- Suite 203, Two Newton Executive Park
- Newton, MA 02462
- United States
Corporate Office
- 2227 Washington Street
- Suite 203, Two Newton Executive Park
- Newton, MA 02462
- United States
ProteoThera Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 30-Oct-2020 | Completed | Out of Business | |||
| 3. Early Stage VC | 22-Dec-2015 | Cancelled | Clinical Trials - Phase 1 | |||
| 2. Early Stage VC | 01-Aug-2014 | $3.1M | $3.1M | Completed | Startup | |
| 1. Grant | 01-Jan-2012 | $1.5M | Completed | Startup |
ProteoThera Patents
ProteoThera Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20170328886-A1 | Systems and methods for determining therapeutic uptake and dosing | Inactive | 13-May-2016 | ||
| EP-3373954-A2 | Methods of producing and purifying matrix-binding fusion proteins by ion-exchange chromatography | Inactive | 10-Nov-2015 | ||
| EP-3373954-A4 | Methods of producing and purifying matrix-binding fusion proteins by ion-exchange chromatography | Inactive | 10-Nov-2015 | ||
| US-20190016754-A1 | Methods of producing and purifying matrix-binding fusion proteins by ion-exchange chromatography | Inactive | 10-Nov-2015 | ||
| WO-2017083491-A2 | Methods of producing and purifying matrix-binding fusion proteins by ion-exchange chromatography | Inactive | 10-Nov-2015 | C07K1/22 |
ProteoThera Signals
ProteoThera FAQs
-
When was ProteoThera founded?
ProteoThera was founded in 2012.
-
Where is ProteoThera headquartered?
ProteoThera is headquartered in Newton, MA.
-
What is the size of ProteoThera?
ProteoThera has 7 total employees.
-
What industry is ProteoThera in?
ProteoThera’s primary industry is Drug Delivery.
-
Is ProteoThera a private or public company?
ProteoThera is a Private company.
-
What is ProteoThera’s current revenue?
The current revenue for ProteoThera is .
-
How much funding has ProteoThera raised over time?
ProteoThera has raised $3.1M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process